These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3299882)

  • 21. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
    Witztum JL; Simmons D; Steinberg D; Beltz WF; Weinreb R; Young SG; Lester P; Kelly N; Juliano J
    Circulation; 1989 Jan; 79(1):16-28. PubMed ID: 2642754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Long term treatment of familial hypercholesterolemia with Colestipol, a new anionic exchange resin (author's transl)].
    Briani G; Fellin R; Balestrieri P; Baggio G; Baiocchi MR; Crepaldi G
    G Ital Cardiol; 1975; 5(3):390-404. PubMed ID: 1149965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection of myocardium by the compensatory mechanism of coronary collaterals after total occlusion of major coronary arteries shown in patients with familial hypercholesterolemia.
    Kuo PT; Kostis JB; Moreyra AE
    Am Heart J; 1982 Jul; 104(1):36-43. PubMed ID: 7090984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of lipid-lowering therapy on the progression of coronary atherosclerosis assessed by scheduled repetitive coronary arteriography.
    Nash DT; Gensini G; Esente P
    Int J Cardiol; 1982; 2(1):43-55. PubMed ID: 7129689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One-year reduction and longitudinal analysis of carotid intima-media thickness associated with colestipol/niacin therapy.
    Mack WJ; Selzer RH; Hodis HN; Erickson JK; Liu CR; Liu CH; Crawford DW; Blankenhorn DH
    Stroke; 1993 Dec; 24(12):1779-83. PubMed ID: 8248954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination drug therapy for familial combined hyperlipidemia.
    East C; Bilheimer DW; Grundy SM
    Ann Intern Med; 1988 Jul; 109(1):25-32. PubMed ID: 3288029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up.
    Cashin-Hemphill L; Mack WJ; Pogoda JM; Sanmarco ME; Azen SP; Blankenhorn DH
    JAMA; 1990 Dec; 264(23):3013-7. PubMed ID: 2243429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen.
    Kane JP; Malloy MJ; Tun P; Phillips NR; Freedman DD; Williams ML; Rowe JS; Havel RJ
    N Engl J Med; 1981 Jan; 304(5):251-8. PubMed ID: 7003391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Premature carotid atherosclerosis: does it occur in both familial hypercholesterolemia and homocystinuria? Ultrasound assessment of arterial intima-media thickness and blood flow velocity.
    Rubba P; Mercuri M; Faccenda F; Iannuzzi A; Irace C; Strisciuglio P; Gnasso A; Tang R; Andria G; Bond MG
    Stroke; 1994 May; 25(5):943-50. PubMed ID: 8165688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Familial hypercholesterolemic xanthomatosis: effect of colestipol on the lipoprotein profile].
    Drouin P; Sauvanet JP; Demange J; Lambert L; Debry G
    Nouv Presse Med; 1980 Nov; 9(42):3186. PubMed ID: 7443475
    [No Abstract]   [Full Text] [Related]  

  • 31. Colestipol in familial type II hyperlipoproteinemia: a three-year trial.
    Harvengt C; Desager JP
    Clin Pharmacol Ther; 1976 Sep; 20(3):310-4. PubMed ID: 182429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density.
    Zambon A; Hokanson JE; Brown BG; Brunzell JD
    Circulation; 1999 Apr; 99(15):1959-64. PubMed ID: 10208998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colestipol plus nicotinic acid in treatment of heterozygous familial hypercholesterolaemia.
    Illingworth DR; Phillipson BE; Rapp JH; Connor WE
    Lancet; 1981 Feb; 1(8215):296-8. PubMed ID: 6109940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diet, drugs, and plasma exchange in the treatment of hyperlipidemia in childhood.
    Mancini M; Postiglione A; Farinaro E; Montefusco S
    Prev Med; 1983 Nov; 12(6):848-53. PubMed ID: 6676732
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of the patient with primary familial heterozygous hypercholesterolemia.
    Avery BR
    J Cardiovasc Nurs; 1995 Jan; 9(2):80-6. PubMed ID: 9197996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of colestipol, clofibrate, and placebo on plasma lipoproteins of patients with hypercholesterolemia.
    Crouse JR; Grundy SM
    Metabolism; 1981 Feb; 30(2):123-8. PubMed ID: 7464561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Colestipol in the treatment of heterozygous familial hypercholesterolemia].
    Ceska R; Sobra J; Toschnerová H; Traurig J
    Cas Lek Cesk; 1992 Mar; 131(4):118-20. PubMed ID: 1581939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of hypercholesterolemia. Can it retard atherogenesis?
    Untereker WJ
    Int J Cardiol; 1982; 2(1):57-9. PubMed ID: 7129690
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of colestipol on plasma lipids in patients affected by type Ii primary hyperlipoproteinaemia (author's transl)].
    Drouin P; Sauvanet JP; Lambert D; Mejean L; Debry G
    Therapie; 1980; 35(4):457-64. PubMed ID: 7466730
    [No Abstract]   [Full Text] [Related]  

  • 40. Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia.
    Weisweiler P
    Metabolism; 1989 Mar; 38(3):271-4. PubMed ID: 2918846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.